Ignite Creation Date:
2024-05-05 @ 10:09 PM
Last Modification Date:
2024-10-26 @ 10:14 AM
Study NCT ID:
NCT01042509
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2010-01-04
Brief Title:
Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease
Sponsor:
Organization:
Hospital Universitario Dr Jose E Gonzalez